These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats. Murakami K; Okajima K; Uchiba M; Harada N; Johno M; Okabe H; Takatsuki K Dig Dis Sci; 1997 Feb; 42(2):319-25. PubMed ID: 9052513 [TBL] [Abstract][Full Text] [Related]
11. Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells. Hahm KB; Park IS; Kim YS; Kim JH; Cho SW; Lee SI; Youn JK Free Radic Biol Med; 1997; 22(4):711-6. PubMed ID: 9013134 [TBL] [Abstract][Full Text] [Related]
12. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study. Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232 [TBL] [Abstract][Full Text] [Related]
13. Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity. Yamada S; Naito Y; Takagi T; Mizushima K; Horie R; Fukumoto K; Inoue K; Harusato A; Uchiyama K; Handa O; Yagi N; Ichikawa H; Yoshikawa T J Gastroenterol Hepatol; 2012 Dec; 27(12):1816-24. PubMed ID: 23020299 [TBL] [Abstract][Full Text] [Related]
14. Effects of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats. Kokura S; Yoshikawa T; Naito Y; Ichikawa H; Takano H; Takahashi S; Tomii T; Yoshida N; Kondo M Dig Dis Sci; 1997 Dec; 42(12):2566-71. PubMed ID: 9440637 [TBL] [Abstract][Full Text] [Related]
15. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils. Sakurai K; Osaka T; Yamasaki K Dig Dis Sci; 2005 Oct; 50 Suppl 1():S90-6. PubMed ID: 16184427 [TBL] [Abstract][Full Text] [Related]
16. The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells. Joh T; Takezono Y; Oshima T; Sasaki M; Seno K; Yokoyama Y; Ohara H; Nomura T; Alexander JS; Itoh M Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():133-8. PubMed ID: 12925151 [TBL] [Abstract][Full Text] [Related]
17. In vitro studies indicating antioxidative properties of rebamipide. Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224 [TBL] [Abstract][Full Text] [Related]
18. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372 [TBL] [Abstract][Full Text] [Related]
19. Rebamipide decreases the susceptibility of gastric mucosa to acid-induced injury in rats by inhibiting neutrophil activation. Harada N; Okajima K; Liu W Dig Dis Sci; 2005 Oct; 50 Suppl 1():S56-62. PubMed ID: 16184422 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of taurine on indomethacin-induced gastric mucosal injury. Son M; Kim HK; Kim WB; Yang J; Kim BK Adv Exp Med Biol; 1996; 403():147-55. PubMed ID: 8915352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]